Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial

BACKGROUND: The appropriate administration regimen of polymyxin B is yet controversial. The present study aimed to explore the optimal dose of polymyxin B under therapeutic drug monitoring (TDM) guidance. METHODS: In China’s Henan province, 26 hospitals participated in a randomized controlled trial....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaohua, Wu, Ying, Qi, Shaoyan, Shao, Huanzhang, Feng, Min, Xing, Lihua, Liu, Hongmei, Gao, Yanqiu, Zhu, Zhiqiang, Zhang, Shuguang, Du, Yuming, Lu, Yibin, Yang, Jing, Chen, Pingyan, Sun, Tongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262552/
https://www.ncbi.nlm.nih.gov/pubmed/37312218
http://dx.doi.org/10.1186/s13054-023-04522-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262552/
https://www.ncbi.nlm.nih.gov/pubmed/37312218
http://dx.doi.org/10.1186/s13054-023-04522-6

Ejemplares similares